Cost effectiveness of adopting a postoperative delirium risk prediction tool with non-pharmacological delirium prevention interventions for surgical patients

Abstract

AbstractBackgroundPostoperative delirium arises among older surgical patients. Screening followed by prevention efforts are recommended. A risk prediction tool has been developed yet the performance and whether adoption is cost-effective are unknown.ObjectiveTo estimate the expected change to ‘total costs’ and ‘health benefits’ measured by quality adjusted life years from a decision to adopt PIPRA plus for screening purpose to find at-risk individuals who are then offered non-pharmacological interventions to reduce risks of postoperative delirium.DesignCost effectiveness modelling study that draws on a range of relevant data sources.SettingSwiss healthcare system.SubjectsSurgical inpatients aged 60 or older, excluding cardiac and intracranial surgeries.MethodsA decision tree model was used to capture the events likely to impact on cost and health outcomes. Information was harvested from a prospective before-after study and augmented with other relevant data sources. Probabilistic sensitivity analysis was undertaken to reveal the probability that adoption was cost effective against a stated maximum willingness to pay threshold for decision making in Switzerland.ResultsPatients in both phases of the study were similar. Costs were lower by 3075CHF (SD 997) per patient with the adoption of the risk screening tool and there was a modest gain to health benefits of 0.01 QALY (SD 0.026). There was a 100% probability that adoption would be cost saving and a 91% probability that adoption would be cost-effective.ConclusionsWe provide early-stage evidence that a decision to adopt the risk screening tool and offer risk reducing interventions will be cost-effective.Key pointsMany surgical patients suffer from post operative delirium.Screening and early intervention can reduce risks and improve outcomes.It is important to establish whether screening and early intervention is cost effective.